In recent years, stem cell therapy has become a very promising and advanced scientific
research topic. The development of treatment methods has evoked great expectations. This …

With the development of regenerative medicine, a variety of mesenchymal stem cells
(MSCs) are increasingly considered for the treatment of premature ovarian failure (POF) …

Stem cells including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs)
and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and …

Human amniotic epithelial cells (hAECs) derived from placental tissues have gained
considerable attention in the field of regenerative medicine. hAECs possess embryonic stem …

Reproductive disorders, including intrauterine adhesion (IUA), premature ovarian
insufficiency (POI), and polycystic ovary syndrome (PCOS), are great threats to female …

BACKGROUND Premature ovarian failure (POF) affects many adult women less than 40
years of age and leads to infertility. According to previous reports, various tissue-specific …

Primary ovarian insufficiency (POI) is defined as a reduction in ovarian function before the
expected age of menopause. POI is known to increase the risk of cardiovascular disorders …

Background Premature ovarian failure (POF) has a great impact on reproductive endocrine
function in females, and it is an important cause of infertility. Previous studies have …

Premature ovarian failure (POF) is one of the most common complications among female
patients with tumors treated with chemotherapy and requires advanced treatment strategies …

Background Human amniotic epithelial cells (hAECs) are attractive candidates for
regenerative medical therapy, with the potential to replace deficient cells and improve …